South Korea’s proportion of hard-core vegetarians has turned out to be a minimal 7.6 percent, with 92.4 percent being non-vegetarians, according to a survey by the Korea Agro-Fisheries & Food Trade Corp. on 5,510 adult respondents.
The survey was delegated by local pollster Global Research based on seven levels of vegetarian practice.
The ‘flexitarians,' or vegetarians who eat meat on occasion, made up 79.7 percent of the population or 333 persons.
The ‘pollos' who eat milk, eggs, fish, and chicken but not beef or pork made up 11% of the population, whereas the 'pescos,' who only consume seafood, comprised 6.2 percent.
In total, flexitarians, pollos, and pescanos accounted for 96.9 percent of the population.
Only 3.1 percent of vegetarians ate no meat of any kind. That's 0.2 percent of all respondents in the poll.
Only 0.7 percent of the group were classified as ‘lacto-ovos,' those who eat only eggs and milk, while 1.4 percent comprised the ‘ovos,' or egg eaters, who do not consume milk.
Of the respondents, 0.5 percent were made up of persons labeled with the term ‘lactos,' who eat fruits, vegetables, and milk, and another 0.5 percent were vegans,' who only consume vegetables and fruits.


Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 



